Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
about
Metformin inhibits the proliferation of benign prostatic epithelial cellsAssociations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway.Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.Is there room for behavioral and modifiable health-related targets in the lower urinary tract symptoms' scenario.The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery.The role of prostate inflammation and fibrosis in lower urinary tract symptoms.Inflammatory mediators in the development and progression of benign prostatic hyperplasia.Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach.Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia.Benign prostatic hyperplasia surgical scoring (BPHSS): an novel scoring system for the perioperative outcomes of holmium laser enucleation of the prostate.Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort.Stimulators and activators of soluble guanylate cyclase for urogenital disorders.Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base.Metabolic syndrome and benign prostatic hyperplasia: An update.Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptomsComparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders
P2860
Q36295425-AE596802-75DB-48A0-B359-70DA9FDDF069Q37274150-823303DE-9818-4B8E-8E21-09E51F529CE1Q37652222-4A41ACAB-FF1D-44DB-954A-40DCE7572105Q37678957-43E02AA2-D579-4FA5-B8A6-786355968BC7Q38765727-E904F31A-A8C9-4FB3-9AD8-5D02D13BB834Q38901781-400087D6-9181-49AD-8C76-A3F05E092C44Q38903901-B25F1556-F68A-4352-AB8A-9CBD8CA7A4F8Q38968019-69F49A97-7A9D-4B13-9394-66D540CB7D9EQ39294665-A5263F00-4CE4-4356-900D-5FBE4DBB1F11Q46493226-5F5AAFF8-DC0F-4699-8663-8B28C0C339DDQ47192868-3ACAF239-164E-4607-A97F-3640128B5A25Q47570403-28A2320D-12EE-4F29-9F80-8CAE84F5774CQ47603923-A3272F8F-C458-4142-B108-BB71E3575CE8Q50054306-C28588E7-5E60-4BB3-A2E5-E640651E7DB7Q55345009-37B16766-AD2A-4A73-9CFE-2F1FB426FF09Q58555982-37132A56-3F0F-4494-A901-4A344A259B44Q58802199-8DC88EFE-A51F-4665-87D3-7AD79F6B1499
P2860
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
@en
type
label
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
@en
prefLabel
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
@en
P2860
P356
P1476
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
@en
P2093
Linda Vignozzi
Mauro Gacci
P2860
P2888
P304
P356
10.1038/NRUROL.2015.301
P407
P50
P577
2016-01-12T00:00:00Z
P6179
1004956337